CSL730

BIOLOGICAL2 trials

Sponsors

CSL Behring

Conditions

HealthyImmune Complex-mediated Autoimmune Diseases

Phase 1

Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults

TerminatedNCT03375606

CSL BehringHealthy

Start: 2018-01-10End: 2020-06-22Updated: 2021-06-03

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects

TerminatedNCT04446000

CSL BehringImmune Complex-mediated Autoimmune Diseases

Start: 2020-09-23End: 2023-03-28Updated: 2023-11-29